Nexteq PLC
28 July 2026
Nexteq plc
("Nexteq" or the "Group")
Director/PDMR Shareholding
Nexteq (AIM: NXQ), a leading technology solutions provider to customers in selected industrial markets, announces that it has been notified that Deborah Wilkinson, Non-Executive Chair of Audit and Risk Committee, has purchased 11,078 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 48.68 pence per Ordinary Share. Subsequent to the purchase Deborah Wilkinson's holding in the Company is 23,006 Ordinary Shares, representing 0.04 per cent of the Company's issued share capital.
|
Nexteq plc Duncan Faithfull, Chief Executive Officer Matt Staight, Chief Financial Officer |
Tel: +44 (0)20 3597 6800 |
|
Nominated Adviser and Broker: Cavendish Capital Markets Ltd Matt Goode / Teddy Whiley / Andrea Callaghan (Corporate Finance) Harriet Ward (ECM) |
Tel: +44 (0) 20 7220 0500 |
|
Financial PR: Alma Strategic Communications Hilary Buchanan / Emma Thompson |
Tel: +44 (0)20 3405 0205 |
About Nexteq
Nexteq (AIM: NXQ) is a strategic technology solutions provider to customers in selected industrial markets. Its innovative technology enables the manufacturers of global electronic equipment to outsource the design, development and supply of non-core aspects of their product offering. By outsourcing elements of their technology stack to Nexteq, customers can focus their product development effort on the most critical drivers of their business' success.
Our solutions are delivered through a global sales team and leverage the Group's electronic hardware, software, display and mechanical engineering expertise. Our Taiwan operation is at the heart of Asian supply networks and facilitates cost effective manufacturing and strategic supply chain management.
The Group operates in six countries and services over 500 customers across 47 countries.
Nexteq operates two distinct brands: Quixant, a specialised computer platforms provider, and Densitron, leaders in human machine interface technology, each with dedicated sales, account management and product innovation teams. Founded in 2005, and later floating on the London Stock Exchange's AIM stock market as Quixant plc, the Group rebranded to Nexteq in 2023.
Further information on Nexteq and its divisions can be found atwww.nexteqplc.com.
The notifications below are made in accordance with Article 19(3) of the Market Abuse Regulation:
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||
|
a) |
Deborah Wilkinson |
||||
|
2 |
Reason for the notification |
||||
|
a) |
Position/status |
Non-Executive Chair of Audit and Risk Committee |
|||
|
b) |
Initial notification /Amendment |
Initial Notification |
|||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
Nexteq plc |
|||
|
b) |
LEI |
2138003VERSWQP561X71 |
|||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary shares of 0.1 pence each |
|||
|
Identification code |
GB00B99PCP71 |
||||
|
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
|||
|
c) |
Price(s) and volume(s) |
||||
|
Sale of Ordinary Shares: |
|||||
|
Price(s) |
Volume(s) |
||||
|
48.68 pence |
11,078 |
||||
|
d) |
Aggregated information Purchase of Ordinary Shares: |
||||
|
- Aggregated volume |
11,078 Ordinary Shares |
||||
|
- Price |
As above |
||||
|
e) |
Date of the transactions |
27 July 2026 |
|||
|
f) |
Place of the transaction |
London Stock Exchange |
|||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.